Among patients with CAD, PTSD is associated with both incident and recurrent heart failure hospitalizations. Post-traumatic stress disorder (PTSD) is linked with incident and recurrent heart failure ...

These data represent one of the largest clinical development programs to date for adults living with PTSD and a significant development in a therapy area that hasn’t seen a new approval for a ...

Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...

According to the letter, the application could not be approved due to lack of substantial efficacy from the submitted studies. The Food and Drug Administration (FDA) has issued a Complete Response ...

About 8% of Americans will experience post-traumatic stress disorder at some point in their lives, but there are still few effective options to treat the condition. “There are some medical treatments ...

The results will be used to seek FDA approval of MDMA, also known as ecstasy, as a treatment for post-traumatic stress disorder. Treating post-traumatic stress disorder (PTSD) with a combination of ...

A web of altered neurochemical pathways and physical brain changes result in post-traumatic stress disorder, or PTSD. The interplay between cortisol dysregulation, heightened norepinephrine levels, ...

Compass Pathways has navigated to another successful midphase readout, linking its psilocybin therapy and psychological support to improvements in post-traumatic stress disorder (PTSD) in a small ...